![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1066.jpg)
Concomitant chemotherapy
HR IC 95% p
Gain absolu à 5 ans
DFS
0,78
0,70-0,87 0,000005
8 %
11
Regional control
0,76
0,68-086 0,000003
9 %
Distant disease free surv
0,81
0,72-0,91
0,0004
7 %
Overall survival
0,81
0,71-0,91
0,0006
6 %